Despite some limitations and high valuations, the region is an attractive place to invest in direct secondaries.
3 min read · 15 September 2015
The Miami-based firm is adding to its European real estate assets in a direct secondaries deal involving Portuguese real estate and secured loan assets.
1 min read · 14 September 2015
As the secondaries market matures, strategies have become more diverse. Ardian, Azini Capital and 17Capital are three firms that stand out.
3 min read · 08 September 2015
The Asian direct secondaries firm has started making distributions from its latest direct secondaries fund, which held final close about a year ago.
2 min read · 04 September 2015
Portfolios of funds that were impacted by the global financial crisis are now ripe for picking, according to Michel Galeazzi, co-founder of Zurich-based Evoco.
2 min read · 20 July 2015
With the promotion of Katie Stitch and Blake Heston, the New York-based direct secondaries firm now has seven managing directors.
1 min read · 07 July 2015
Leerink Capital Partners recently raised a new $192 million fund along with Revelation Partners to invest in direct secondaries in healthcare companies. Scott Halsted, managing director at Revelation, explains the strategy and the current environment for healthcare secondaries investments.
3 min read · 02 July 2015
In addition to the rebranding, Tim Draper also plans to spend more time investing with the firm’s team. Successful investments include Horizon Discovery, a personalised medicine company.
1 min read · 01 July 2015
Facing competitors with deep pockets and inflated valuations, many traditional direct secondaries investors are steering clear of shiny ‘unicorns’.
3 min read · 26 June 2015
With strong deal flow and high pricing expectations, demand for direct secondaries is robust, but the market also tends to reflect a disconnect to the fundamentals, according to Hans Swildens, chief executive and founder of Industry Ventures.
3 min read · 22 June 2015
